Medical Care
Global Prostate Specific Antigen (PSA) Testing Market Research Report 2025
- Apr 07, 25
- ID: 167565
- Pages: 99
- Figures: 97
- Views: 33
The global market for Prostate Specific Antigen (PSA) Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Prostate Specific Antigen (PSA) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prostate Specific Antigen (PSA) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prostate Specific Antigen (PSA) Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, Roche Holding AG, Beckman Coulter, Mediwatch(LABORIE), Boditech, Bristol Myers Squibb, GE Healthcare, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen (PSA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen (PSA) Testing.
The Prostate Specific Antigen (PSA) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Specific Antigen (PSA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Specific Antigen (PSA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck
Segment by Type
Radioimmunoassay
Enzyme Immunoassay
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Prostate Specific Antigen (PSA) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prostate Specific Antigen (PSA) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prostate Specific Antigen (PSA) Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, Roche Holding AG, Beckman Coulter, Mediwatch(LABORIE), Boditech, Bristol Myers Squibb, GE Healthcare, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen (PSA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen (PSA) Testing.
The Prostate Specific Antigen (PSA) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Specific Antigen (PSA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Specific Antigen (PSA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck
Segment by Type
Radioimmunoassay
Enzyme Immunoassay
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radioimmunoassay
1.2.3 Enzyme Immunoassay
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institute
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Testing Market Perspective (2020-2031)
2.2 Global Prostate Specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Specific Antigen (PSA) Testing Historic Market Size by Region (2020-2025)
2.2.3 Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2026-2031)
2.3 Prostate Specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue (2020-2025)
3.1.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Specific Antigen (PSA) Testing Revenue
3.4 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Testing Revenue in 2024
3.5 Global Key Players of Prostate Specific Antigen (PSA) Testing Head office and Area Served
3.6 Global Key Players of Prostate Specific Antigen (PSA) Testing, Product and Application
3.7 Global Key Players of Prostate Specific Antigen (PSA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Type (2020-2025)
4.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2026-2031)
5 Prostate Specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Application (2020-2025)
5.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
6.2 North America Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
6.4 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
7.2 Europe Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
7.4 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
9.2 Latin America Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
9.4 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cleveland Diagnostics
11.1.1 Cleveland Diagnostics Company Details
11.1.2 Cleveland Diagnostics Business Overview
11.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Introduction
11.1.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.1.5 Cleveland Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Prostate Specific Antigen (PSA) Testing Introduction
11.2.4 Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Introduction
11.3.4 Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 DiaSorin
11.4.1 DiaSorin Company Details
11.4.2 DiaSorin Business Overview
11.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Introduction
11.4.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.4.5 DiaSorin Recent Development
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Details
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Introduction
11.5.4 Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.5.5 Roche Holding AG Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Introduction
11.6.4 Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.6.5 Beckman Coulter Recent Development
11.7 Mediwatch(LABORIE)
11.7.1 Mediwatch(LABORIE) Company Details
11.7.2 Mediwatch(LABORIE) Business Overview
11.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Introduction
11.7.4 Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.7.5 Mediwatch(LABORIE) Recent Development
11.8 Boditech
11.8.1 Boditech Company Details
11.8.2 Boditech Business Overview
11.8.3 Boditech Prostate Specific Antigen (PSA) Testing Introduction
11.8.4 Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.8.5 Boditech Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Introduction
11.9.4 Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.9.5 Bristol Myers Squibb Recent Development
11.10 GE Healthcare
11.10.1 GE Healthcare Company Details
11.10.2 GE Healthcare Business Overview
11.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Introduction
11.10.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.10.5 GE Healthcare Recent Development
11.11 Endocare
11.11.1 Endocare Company Details
11.11.2 Endocare Business Overview
11.11.3 Endocare Prostate Specific Antigen (PSA) Testing Introduction
11.11.4 Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.11.5 Endocare Recent Development
11.12 GlaxoSmith Kline
11.12.1 GlaxoSmith Kline Company Details
11.12.2 GlaxoSmith Kline Business Overview
11.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Introduction
11.12.4 GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.12.5 GlaxoSmith Kline Recent Development
11.13 Anixa Biosciences
11.13.1 Anixa Biosciences Company Details
11.13.2 Anixa Biosciences Business Overview
11.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Introduction
11.13.4 Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.13.5 Anixa Biosciences Recent Development
11.14 Ortho Clinical
11.14.1 Ortho Clinical Company Details
11.14.2 Ortho Clinical Business Overview
11.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Introduction
11.14.4 Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.14.5 Ortho Clinical Recent Development
11.15 Fujirebio
11.15.1 Fujirebio Company Details
11.15.2 Fujirebio Business Overview
11.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Introduction
11.15.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.15.5 Fujirebio Recent Development
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Prostate Specific Antigen (PSA) Testing Introduction
11.16.4 Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.16.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radioimmunoassay
1.2.3 Enzyme Immunoassay
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institute
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Testing Market Perspective (2020-2031)
2.2 Global Prostate Specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Specific Antigen (PSA) Testing Historic Market Size by Region (2020-2025)
2.2.3 Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2026-2031)
2.3 Prostate Specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue (2020-2025)
3.1.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Specific Antigen (PSA) Testing Revenue
3.4 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Testing Revenue in 2024
3.5 Global Key Players of Prostate Specific Antigen (PSA) Testing Head office and Area Served
3.6 Global Key Players of Prostate Specific Antigen (PSA) Testing, Product and Application
3.7 Global Key Players of Prostate Specific Antigen (PSA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Type (2020-2025)
4.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2026-2031)
5 Prostate Specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Application (2020-2025)
5.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
6.2 North America Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
6.4 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
7.2 Europe Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
7.4 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
9.2 Latin America Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
9.4 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size (2020-2031)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cleveland Diagnostics
11.1.1 Cleveland Diagnostics Company Details
11.1.2 Cleveland Diagnostics Business Overview
11.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Introduction
11.1.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.1.5 Cleveland Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Prostate Specific Antigen (PSA) Testing Introduction
11.2.4 Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Introduction
11.3.4 Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 DiaSorin
11.4.1 DiaSorin Company Details
11.4.2 DiaSorin Business Overview
11.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Introduction
11.4.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.4.5 DiaSorin Recent Development
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Details
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Introduction
11.5.4 Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.5.5 Roche Holding AG Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Introduction
11.6.4 Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.6.5 Beckman Coulter Recent Development
11.7 Mediwatch(LABORIE)
11.7.1 Mediwatch(LABORIE) Company Details
11.7.2 Mediwatch(LABORIE) Business Overview
11.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Introduction
11.7.4 Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.7.5 Mediwatch(LABORIE) Recent Development
11.8 Boditech
11.8.1 Boditech Company Details
11.8.2 Boditech Business Overview
11.8.3 Boditech Prostate Specific Antigen (PSA) Testing Introduction
11.8.4 Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.8.5 Boditech Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Introduction
11.9.4 Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.9.5 Bristol Myers Squibb Recent Development
11.10 GE Healthcare
11.10.1 GE Healthcare Company Details
11.10.2 GE Healthcare Business Overview
11.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Introduction
11.10.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.10.5 GE Healthcare Recent Development
11.11 Endocare
11.11.1 Endocare Company Details
11.11.2 Endocare Business Overview
11.11.3 Endocare Prostate Specific Antigen (PSA) Testing Introduction
11.11.4 Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.11.5 Endocare Recent Development
11.12 GlaxoSmith Kline
11.12.1 GlaxoSmith Kline Company Details
11.12.2 GlaxoSmith Kline Business Overview
11.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Introduction
11.12.4 GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.12.5 GlaxoSmith Kline Recent Development
11.13 Anixa Biosciences
11.13.1 Anixa Biosciences Company Details
11.13.2 Anixa Biosciences Business Overview
11.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Introduction
11.13.4 Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.13.5 Anixa Biosciences Recent Development
11.14 Ortho Clinical
11.14.1 Ortho Clinical Company Details
11.14.2 Ortho Clinical Business Overview
11.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Introduction
11.14.4 Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.14.5 Ortho Clinical Recent Development
11.15 Fujirebio
11.15.1 Fujirebio Company Details
11.15.2 Fujirebio Business Overview
11.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Introduction
11.15.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.15.5 Fujirebio Recent Development
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Prostate Specific Antigen (PSA) Testing Introduction
11.16.4 Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
11.16.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radioimmunoassay
Table 3. Key Players of Enzyme Immunoassay
Table 4. Global Prostate Specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2020-2025)
Table 8. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2026-2031)
Table 10. Prostate Specific Antigen (PSA) Testing Market Trends
Table 11. Prostate Specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate Specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate Specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate Specific Antigen (PSA) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Prostate Specific Antigen (PSA) Testing Market Share by Players (2020-2025)
Table 16. Global Top Prostate Specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2024)
Table 17. Ranking of Global Top Prostate Specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Prostate Specific Antigen (PSA) Testing, Headquarters and Area Served
Table 20. Global Key Players of Prostate Specific Antigen (PSA) Testing, Product and Application
Table 21. Global Key Players of Prostate Specific Antigen (PSA) Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cleveland Diagnostics Company Details
Table 47. Cleveland Diagnostics Business Overview
Table 48. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product
Table 49. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 50. Cleveland Diagnostics Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Prostate Specific Antigen (PSA) Testing Product
Table 54. Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Siemens Healthineers Company Details
Table 57. Siemens Healthineers Business Overview
Table 58. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product
Table 59. Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers Recent Development
Table 61. DiaSorin Company Details
Table 62. DiaSorin Business Overview
Table 63. DiaSorin Prostate Specific Antigen (PSA) Testing Product
Table 64. DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 65. DiaSorin Recent Development
Table 66. Roche Holding AG Company Details
Table 67. Roche Holding AG Business Overview
Table 68. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product
Table 69. Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 70. Roche Holding AG Recent Development
Table 71. Beckman Coulter Company Details
Table 72. Beckman Coulter Business Overview
Table 73. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product
Table 74. Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 75. Beckman Coulter Recent Development
Table 76. Mediwatch(LABORIE) Company Details
Table 77. Mediwatch(LABORIE) Business Overview
Table 78. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product
Table 79. Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 80. Mediwatch(LABORIE) Recent Development
Table 81. Boditech Company Details
Table 82. Boditech Business Overview
Table 83. Boditech Prostate Specific Antigen (PSA) Testing Product
Table 84. Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 85. Boditech Recent Development
Table 86. Bristol Myers Squibb Company Details
Table 87. Bristol Myers Squibb Business Overview
Table 88. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product
Table 89. Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 90. Bristol Myers Squibb Recent Development
Table 91. GE Healthcare Company Details
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Prostate Specific Antigen (PSA) Testing Product
Table 94. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 95. GE Healthcare Recent Development
Table 96. Endocare Company Details
Table 97. Endocare Business Overview
Table 98. Endocare Prostate Specific Antigen (PSA) Testing Product
Table 99. Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 100. Endocare Recent Development
Table 101. GlaxoSmith Kline Company Details
Table 102. GlaxoSmith Kline Business Overview
Table 103. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product
Table 104. GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 105. GlaxoSmith Kline Recent Development
Table 106. Anixa Biosciences Company Details
Table 107. Anixa Biosciences Business Overview
Table 108. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product
Table 109. Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 110. Anixa Biosciences Recent Development
Table 111. Ortho Clinical Company Details
Table 112. Ortho Clinical Business Overview
Table 113. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product
Table 114. Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 115. Ortho Clinical Recent Development
Table 116. Fujirebio Company Details
Table 117. Fujirebio Business Overview
Table 118. Fujirebio Prostate Specific Antigen (PSA) Testing Product
Table 119. Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 120. Fujirebio Recent Development
Table 121. Merck Company Details
Table 122. Merck Business Overview
Table 123. Merck Prostate Specific Antigen (PSA) Testing Product
Table 124. Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 125. Merck Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Testing Picture
Figure 2. Global Prostate Specific Antigen (PSA) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Specific Antigen (PSA) Testing Market Share by Type: 2024 VS 2031
Figure 4. Radioimmunoassay Features
Figure 5. Enzyme Immunoassay Features
Figure 6. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Prostate Specific Antigen (PSA) Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Research Institute Case Studies
Figure 12. Others Case Studies
Figure 13. Prostate Specific Antigen (PSA) Testing Report Years Considered
Figure 14. Global Prostate Specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Specific Antigen (PSA) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Specific Antigen (PSA) Testing Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Specific Antigen (PSA) Testing Market Share by Players in 2024
Figure 18. Global Top Prostate Specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2024
Figure 20. North America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 22. United States Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 26. Germany Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Share by Region (2020-2031)
Figure 34. China Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 51. Siemens Healthineers Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 52. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 53. Roche Holding AG Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 54. Beckman Coulter Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 55. Mediwatch(LABORIE) Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 56. Boditech Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 59. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 60. GlaxoSmith Kline Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 61. Anixa Biosciences Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 62. Ortho Clinical Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 63. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 64. Merck Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radioimmunoassay
Table 3. Key Players of Enzyme Immunoassay
Table 4. Global Prostate Specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2020-2025)
Table 8. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2026-2031)
Table 10. Prostate Specific Antigen (PSA) Testing Market Trends
Table 11. Prostate Specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate Specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate Specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate Specific Antigen (PSA) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Prostate Specific Antigen (PSA) Testing Market Share by Players (2020-2025)
Table 16. Global Top Prostate Specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2024)
Table 17. Ranking of Global Top Prostate Specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Prostate Specific Antigen (PSA) Testing, Headquarters and Area Served
Table 20. Global Key Players of Prostate Specific Antigen (PSA) Testing, Product and Application
Table 21. Global Key Players of Prostate Specific Antigen (PSA) Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cleveland Diagnostics Company Details
Table 47. Cleveland Diagnostics Business Overview
Table 48. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product
Table 49. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 50. Cleveland Diagnostics Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Prostate Specific Antigen (PSA) Testing Product
Table 54. Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Siemens Healthineers Company Details
Table 57. Siemens Healthineers Business Overview
Table 58. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product
Table 59. Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers Recent Development
Table 61. DiaSorin Company Details
Table 62. DiaSorin Business Overview
Table 63. DiaSorin Prostate Specific Antigen (PSA) Testing Product
Table 64. DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 65. DiaSorin Recent Development
Table 66. Roche Holding AG Company Details
Table 67. Roche Holding AG Business Overview
Table 68. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product
Table 69. Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 70. Roche Holding AG Recent Development
Table 71. Beckman Coulter Company Details
Table 72. Beckman Coulter Business Overview
Table 73. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product
Table 74. Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 75. Beckman Coulter Recent Development
Table 76. Mediwatch(LABORIE) Company Details
Table 77. Mediwatch(LABORIE) Business Overview
Table 78. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product
Table 79. Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 80. Mediwatch(LABORIE) Recent Development
Table 81. Boditech Company Details
Table 82. Boditech Business Overview
Table 83. Boditech Prostate Specific Antigen (PSA) Testing Product
Table 84. Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 85. Boditech Recent Development
Table 86. Bristol Myers Squibb Company Details
Table 87. Bristol Myers Squibb Business Overview
Table 88. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product
Table 89. Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 90. Bristol Myers Squibb Recent Development
Table 91. GE Healthcare Company Details
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Prostate Specific Antigen (PSA) Testing Product
Table 94. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 95. GE Healthcare Recent Development
Table 96. Endocare Company Details
Table 97. Endocare Business Overview
Table 98. Endocare Prostate Specific Antigen (PSA) Testing Product
Table 99. Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 100. Endocare Recent Development
Table 101. GlaxoSmith Kline Company Details
Table 102. GlaxoSmith Kline Business Overview
Table 103. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product
Table 104. GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 105. GlaxoSmith Kline Recent Development
Table 106. Anixa Biosciences Company Details
Table 107. Anixa Biosciences Business Overview
Table 108. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product
Table 109. Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 110. Anixa Biosciences Recent Development
Table 111. Ortho Clinical Company Details
Table 112. Ortho Clinical Business Overview
Table 113. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product
Table 114. Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 115. Ortho Clinical Recent Development
Table 116. Fujirebio Company Details
Table 117. Fujirebio Business Overview
Table 118. Fujirebio Prostate Specific Antigen (PSA) Testing Product
Table 119. Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 120. Fujirebio Recent Development
Table 121. Merck Company Details
Table 122. Merck Business Overview
Table 123. Merck Prostate Specific Antigen (PSA) Testing Product
Table 124. Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2020-2025) & (US$ Million)
Table 125. Merck Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Testing Picture
Figure 2. Global Prostate Specific Antigen (PSA) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Specific Antigen (PSA) Testing Market Share by Type: 2024 VS 2031
Figure 4. Radioimmunoassay Features
Figure 5. Enzyme Immunoassay Features
Figure 6. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Prostate Specific Antigen (PSA) Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Research Institute Case Studies
Figure 12. Others Case Studies
Figure 13. Prostate Specific Antigen (PSA) Testing Report Years Considered
Figure 14. Global Prostate Specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Specific Antigen (PSA) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Specific Antigen (PSA) Testing Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Specific Antigen (PSA) Testing Market Share by Players in 2024
Figure 18. Global Top Prostate Specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2024
Figure 20. North America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 22. United States Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 26. Germany Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Share by Region (2020-2031)
Figure 34. China Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 51. Siemens Healthineers Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 52. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 53. Roche Holding AG Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 54. Beckman Coulter Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 55. Mediwatch(LABORIE) Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 56. Boditech Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 59. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 60. GlaxoSmith Kline Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 61. Anixa Biosciences Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 62. Ortho Clinical Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 63. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 64. Merck Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232